UNIGE document Scientific Article
previous document  unige:94588  next document
add to browser collection

HeartMate 3 in Lowest INTERMACS Profile Cohort: The Swiss Experience

Tozzi, Piergiorgio
Ahmadov, Kameran
Hullin, Roger
Liaudet, Lucas
show hidden authors show all authors [1 - 10]
Published in ASAIO Journal. 2017, vol. 63, no. 6, p. 752-758
Abstract New generation devices for long-term mechanical circulatory support are centrifugal pumps having fully magnetically levitated rotors to reduce blood trauma. Recently, the novel HeartMate 3 was cleared for clinical application in Switzerland. In two Swiss University Hospitals part of the "Lausanne-Geneva Transplantation Network," 10 consecutive patients in end-stage heart failure received the HeartMate 3. Device implantation criteria were persistent low output syndrome despite optimal medical treatment. The primary end-point of the study was survival or transplantation to 90 days on the device. Five patients (50%) were in INTERMACS class 1 and 2 (two were under venoarterial extracorporeal membrane oxygenation [VA-ECMO]), and five were in class 3 and 4. The indication was bridge-to-transplant in seven patients, and destination therapy in three. Two patients (20%) received concomitant aortic valve surgery. Four patients (40%) required temporary right ventricle support (tRVAD) for a mean of 8 ± 1.5 days. Bleeding requiring surgical revision occurred in five (50%) patients, two during the tRVAD support. At the 90 day end-point, survival was 90%, one (10%) died due to respiratory failure. Three (30%) experienced critical illness polyneuropathy. Two had body temperature over 38.5°C for more than 7 days after implant, without infections. Two (20%) had late driveline infection. The pump allowed rapid improvement of patients' clinical conditions even in severely compromised patients. Postoperative bleeding occurred in the setting of anticoagulation. No hemolysis or pump thrombosis occurred. Fever occurred frequently but was not associated with mortality. Hemodynamic support was consistent over time without significant adverse events.
PMID: 28557861
Full text
Article (Published version) (402 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Dysfonctions cardio-pulmonaires et cérébrales (278)
Groupe de recherche en hémodynamique (913)
(ISO format)
BANFI, Carlo et al. HeartMate 3 in Lowest INTERMACS Profile Cohort: The Swiss Experience. In: ASAIO Journal, 2017, vol. 63, n° 6, p. 752-758. https://archive-ouverte.unige.ch/unige:94588

72 hits

1 download


Deposited on : 2017-06-01

Export document
Format :
Citation style :